Micellar paclitaxel for injection (DrugBank: Paclitaxel)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 46 | 悪性関節リウマチ | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00055133 (ClinicalTrials.gov) | September 2002 | 19/2/2003 | A Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis | A Phase 2 Open-Label Clinical Study Using Intravenous Paxceed™ to Treat Patients With Rheumatoid Arthritis | Rheumatoid Arthritis | Drug: Micellar Paclitaxel for Injection | Angiotech Pharmaceuticals | NULL | Completed | 21 Years | 70 Years | Both | 50 | Phase 2 | United States |